Is Saffron FDA-approved?

Saffron is regulated as a dietary supplement in the US, not as a drug. The FDA does not verify efficacy claims on supplement labels, and product potency varies by brand. Discuss any supplement with a qualified clinician before starting.

Editorial evidence review

Saffron for mood, PMS, and menopausal wellbeing: what the evidence shows

Also known as: Crocus sativus, saffron extract, affron (branded extract)

Evidence grade

Moderate evidence

Meta-analyses of small randomized trials suggest standardized saffron extract improves symptoms of mild-to-moderate depression versus placebo, with some trials reporting effects comparable to low-dose antidepressants. Smaller studies suggest benefit for PMS. Trials are short and often small, and saffron is not a replacement for prescribed treatment of clinical depression.

What is Saffron?

Saffron (Crocus sativus) is a dietary supplement commonly marketed for low mood, mild-to-moderate depression symptoms, PMS. In the US it is regulated as a food, not a drug, so the FDA does not verify label claims or potency. This page summarizes what peer-reviewed research suggests about Saffron and how clinicians typically weigh it against evidence-based prescription options.

Evidence for menopause and hormonal-health uses

Researchers have studied Saffron for several symptom clusters relevant to women in perimenopause and midlife. The strongest evidence, where it exists, is summarized below — framed as what studies suggest rather than as clinical guarantees.

low mood: studies suggest a modest, variable effect — some trials show benefit versus placebo, others do not.
mild-to-moderate depression symptoms: studies suggest a modest, variable effect — some trials show benefit versus placebo, others do not.
PMS: studies suggest a modest, variable effect — some trials show benefit versus placebo, others do not.
perimenopausal mood: studies suggest a modest, variable effect — some trials show benefit versus placebo, others do not.
appetite control: studies suggest a modest, variable effect — some trials show benefit versus placebo, others do not.

Typical dosing

Depression trials most often use 30 mg/day of a standardized extract (commonly 15 mg twice daily) for 6 to 8 weeks. Doses above roughly 1.5 g/day can be toxic, and very high doses are unsafe in pregnancy.

Dosing above is what studies commonly use — it is not a personal medical recommendation.

Side effects and interactions

Common side effects

Mild gastrointestinal upset
Headache or drowsiness
Reduced appetite
High doses (grams per day) can be toxic

Known interactions

Antidepressants (SSRIs and others) — theoretical additive serotonergic effect; discuss with your prescriber
Anticoagulants and antiplatelets — theoretical bleeding risk
Sedatives and blood-pressure medication — theoretical additive effects
Pregnancy — avoid medicinal doses; high amounts can stimulate the uterus

Who should avoid Saffron

Speak to a qualified clinician before starting Saffron if you are pregnant, planning pregnancy, breastfeeding, taking prescription medication, or living with a hormone-sensitive condition, kidney or liver disease, a bleeding disorder, or a thyroid condition. Supplement quality varies by manufacturer, so avoid products that do not disclose third-party testing.

Evidence-based alternatives and clinician-guided options

If you are considering Saffron for perimenopause or midlife hormonal symptoms, a clinician can help weigh it against options with a stronger evidence base — including hormone therapy, non-hormonal prescriptions, and lifestyle interventions. Our editorial reviews cover telehealth providers that can prescribe and monitor these options:

Read our evernow review — Evernow clinicians address perimenopausal mood alongside any supplement discussion.
Read our midi health review — Midi Health includes mood and mental-health screening in perimenopause care.

Weighing costs matters too — our HRT cost estimator compares typical monthly out-of-pocket costs across HRT, non-hormonal Rx, and supplement-only strategies.

Frequently asked questions

Does Saffron help with low mood?: Meta-analyses of small randomized trials suggest standardized saffron extract improves symptoms of mild-to-moderate depression versus placebo, with some trials reporting effects comparable to low-dose antidepressants. Smaller studies suggest benefit for PMS. Trials are short and often small, and saffron is not a replacement for prescribed treatment of clinical depression.
What is a typical dose of Saffron?: Depression trials most often use 30 mg/day of a standardized extract (commonly 15 mg twice daily) for 6 to 8 weeks. Doses above roughly 1.5 g/day can be toxic, and very high doses are unsafe in pregnancy.
Who should avoid Saffron?: Speak to a clinician before starting Saffron if you are pregnant, breastfeeding, taking prescription medication (especially Antidepressants (SSRIs and others)), or living with a chronic condition. Overall, our editorial synthesis rates the evidence as "moderate evidence" — it is not a substitute for medical care.
Is Saffron FDA-approved?: Saffron is regulated as a dietary supplement in the US, not as a drug. The FDA does not verify efficacy claims on supplement labels, and product potency varies by brand. Discuss any supplement with a qualified clinician before starting.